Pages that link to "Q35821691"

The following pages link to Short term treatment of dermatophyte onychomycosis with terbinafine (Q35821691):

Displaying 36 items.

• Network Meta-Analysis of Onychomycosis Treatments (Q26750479) (← links)
• Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections (Q33569526) (← links)
• Clinical and economic factors in the treatment of onychomycosis (Q33571891) (← links)
• Management of onychomycoses (Q33726217) (← links)
• A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis (Q33824841) (← links)
• Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials (Q34137197) (← links)
• Onychomycosis. New therapies for an old disease (Q34184524) (← links)
• Long-term efficacy of antifungals in toenail onychomycosis: a critical review (Q34352760) (← links)
• Update on terbinafine with a focus on dermatophytoses (Q34620230) (← links)
• Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections (Q34721804) (← links)
• Onychomycosis: Current Treatment Options (Q35115113) (← links)
• Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality (Q35166739) (← links)
• Clinical comparison and complete cure rates of Terbinafine efficacy in affected onychomycotic toenails (Q35216449) (← links)
• Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials. (Q35635494) (← links)
• Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis. (Q38033192) (← links)
• Oral antifungal medication for toenail onychomycosis (Q38679387) (← links)
• Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine (Q39671199) (← links)
• How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives (Q39865044) (← links)
• An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates. (Q39927211) (← links)
• Antifungal agents: an overview. Part II. (Q40449449) (← links)
• The epidemiology of onychomycosis in Britain (Q40470751) (← links)
• Oral therapeutic agents in fungal nail disease (Q40698012) (← links)
• Treatment and prophylaxis of tinea infections (Q41139756) (← links)
• Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials (Q41276407) (← links)
• Antifungal therapy, an everlasting battle (Q41655359) (← links)
• Current Issues in Onychomycosis (Q41718745) (← links)
• An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis (Q42676208) (← links)
• Tinea pedis and onychomycosis in Danish soldiers before and after service in ex-Yugoslavia (Q43338649) (← links)
• Onychomycosis: quality of studies (Q44016476) (← links)
• Terbinafine-associated hepatic injury (Q44033076) (← links)
• Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model (Q44704443) (← links)
• Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective (Q46299897) (← links)
• Laser Therapy for Onychomycosis: Fact or Fiction? (Q49412021) (← links)
• Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis. (Q52251500) (← links)
• Guidelines of care for superficial mycotic infections of the skin: onychomycosis. Guidelines/Outcomes Committee. American Academy of Dermatology (Q70843395) (← links)
• Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial (Q73874830) (← links)